Roger G. H. Downer
Geen lopende functies
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Chotchai Charoenngam | M | 61 |
Asian Institute of Technology
| 26 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Paul J. Schechter | M | 84 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 jaar |
Eliot Lurier | M | 66 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 jaar |
Thomas E. Gardner | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 jaar |
Carol L. Amelio | F | 62 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 jaar |
David Holtz | M | 58 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 jaar |
Shao Hua Dai | M | 41 |
University of Limerick
| 1 jaar |
Drajad Widiyanto | M | 60 |
Asian Institute of Technology
| 1 jaar |
Paul Adams | M | - |
University of Limerick
| 1 jaar |
John Shinnick | M | - |
University of Limerick
| 4 jaar |
John Mescall | M | 43 |
University of Limerick
| 4 jaar |
Setiawan Wangsaatmaja | M | 61 |
Asian Institute of Technology
| 2 jaar |
Ross Nicholas | M | - |
University of Limerick
| 4 jaar |
Kate Madden | F | - |
University of Limerick
| 6 jaar |
Elaine Collins | F | - |
University of Limerick
| 4 jaar |
Allan Mulrooney | M | - |
University of Limerick
| 4 jaar |
Audrey Crummy | F | - |
University of Limerick
| 4 jaar |
Shane Clifford | M | - |
University of Limerick
| 4 jaar |
Alan Cuddihy | M | - |
University of Limerick
| 4 jaar |
Aisling Meehan | F | - |
University of Limerick
| 4 jaar |
Paul Kelly | M | - |
University of Limerick
| 4 jaar |
Thongphet Chanthanivong | M | 62 |
Asian Institute of Technology
| 2 jaar |
Keith James McKnight | M | - |
University of Limerick
| 4 jaar |
Thang Minh Nguyen | M | 56 |
Asian Institute of Technology
| 1 jaar |
Dwayne McNicholas | M | - |
University of Limerick
| 4 jaar |
G. A. Fitch | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 1 jaar |
Neil Carragher | M | 85 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 jaar |
Richard W. Zahn | M | 73 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 5 jaar |
Barry Mark Heck | M | 61 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 13 jaar |
Edward Gaj | M | 67 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 3 jaar |
David C. McDowell | M | 68 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 jaar |
Scott H. Gillis | M | 71 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 8 jaar |
Katherine J. Turner | M | 70 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 2 jaar |
David Wills | M | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Paul Gleeson | M | - |
University of Limerick
| 4 jaar |
Irakli Gilauri | M | 48 |
University of Limerick
| 4 jaar |
Antoin Russell | M | - |
University of Limerick
| 2 jaar |
Alan Dunne | M | - |
University of Limerick
| 2 jaar |
Karl-Heinz Rinne | M | - |
University of Limerick
| 5 jaar |
Karen Payne | F | - |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | - |
Martin Mellody | M | - |
University of Limerick
| 1 jaar |
David Poorvin | M | 76 |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | 4 jaar |
Steve Mason | M | - |
University of Limerick
| 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Ierland | 22 | 51.16% |
Verenigde Staten | 16 | 37.21% |
Thailand | 5 | 11.63% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Roger G. H. Downer
- Persoonlijk netwerk